Clinical research

Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device

EuroIntervention 2010;6:54-62.

Hasan Jilaihawi
Hasan Jilaihawi1, MD; Renu Virmani2, MD; Hiroshi Nakagawa3, MD; Anique Ducharme4, MD; Yan-Fen Shi4, MD; Naima Carter-Monroe2, MD; Elena Ladich2, MD; Mano Iyer5, BSc; Atsushi Ikeda3, MD; Anita Asgar1, MD; Raoul Bonan1*, MD
1. Interventional Cardiology, Montréal Heart Institute, Montreal, Canada; 2. Histopathology, CV Path Institute, Gaithersburg, MD, USA; 3. Electrophysiology, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA; 4. Cardi

Aims: To evaluate the potential for mitral annular (MA) size reduction using a novel device utilising therapeutic ultrasound (TU).

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

mitral valve diseasevalvular heart diseasevalvuloplasty
Read next article
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial

Latest news